– Johnson & Johnson beat estimates by 11 cents a share, with quarterly earnings of $2.67 per share. Revenue came in slightly below forecasts.
J&J also suspended sales guidance for its Covid-19 vaccine due to a global supply surplus, and announced a 6.6% dividend hike. Shares initially fell more than 3% in the premarket but subsequently erased those losses.
Nederland Laatste Nieuws, Nederland Headlines
Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.
Bron: NBCDFW - 🏆 288. / 63 Lees verder »
Bron: MarketWatch - 🏆 3. / 97 Lees verder »